中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 6
Jun.  2019
Turn off MathJax
Article Contents

Construction of PSCSI-GFP lentiviral vector for the endothelin-converting enzyme-like 1 gene

DOI: 10.3969/j.issn.1001-5256.2019.06.021
Research funding:

 

  • Received Date: 2018-12-20
  • Published Date: 2019-06-20
  • Objective To design and construct the RNA interference (RNAi) lentiviral vector targeting the endothelin-converting enzyme-like 1 (ECEL1) gene. Methods The RNA interference target was designed with the ECEL1 gene as the template, and the short-hairpin RNA (shRNA) interference sequence was designed based on the selected target sequence. Enzyme cut sites for restriction endonuclease were added to both ends of this sequence to synthesize single-stranded DNA oligo, which was then paired in annealing buffer to form double-stranded DNA oligo. GV115 vectors were linearized by double digestion with Age I and EcoR I enzymes, and then they were connected with the DNA oligo; the grafted product transformed Escherichia coli receptor cells and was amplified, sequenced, and identified by PCR.The recombinant ECEL1 gene RNAi lentivirus was obtained by plasmid extraction, transfection, concentration, and purification, and HIV-1 p24 antigen ELISA was used to determine the titer of the recombinant RNAi lentivirus. Human hepatoma BEL-7404 cells were transfected with the qualified lentivirus, and a control group was set up. Fluorescence observation was performed to determine transfection rate. Real-time PCR and Western blot were used to measure the mRNA and protein expression of target gene after ECEL1 gene knockdown in human hepatoma BEL-7404 cells. The two-independent-samples t test was used for comparison between two groups. Results After the design with the ECEL1 gene as the template, the psc48784 fragment was selected as the target for RNAi; the double-stranded DNA oligo was prepared and the positive recons were identified and sequenced by PCR, and the results showed that psc48784 was the correct clone. The ECEL1 gene RNAi lentivirus was successfully constructed after plasmid extraction, transfection, concentration, and purification and was qualified for physical test and sterility test. HIV-1 p24 antigen ELISA showed that the ECEL1 gene RNAi lentivirus had a virus titer of 3 E+ 8 TU/ml, suggesting that the qualified ECEL1 gene RNAi lentivirus with a high titer was successfully constructed. After the human hepatoma BEL-7404 cells were transfected with the ECEL1 gene RNAi lentivirus, fluorescence observation showed a transfection efficiency of80% and a stable state of cells. Real-time PCR and Western blot showed significant reductions in the mRNA and protein expression of the ECEL1 gene in human hepatoma BEL-7404 cells in the experimental group (P < 0. 05) , and the knockdown efficiency reached 70. 5%.Conclusion The ECEL1 gene PSCSI-GFP lentiviral vector is successfully constructed, and stable virus samples with a high titer are obtained. The stable human hepatoma BEL-7404 cells with ECEL1 gene knockdown are also obtained.

     

  • loading
  • [1]KIRYU-SEO S, NAGATA K, SAIDO TC, et al.New insights of a neuronal peptidase DINE/ECEL1:Nerve development, nerve regeneration and neurogenic pathogenesis[J].Neurochem Res, 2018.[Epub ahead of print]
    [2]KIRYU-SEO S, SASAKI M, YOKOHAMA H, et al.Damageinduced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers[J].Proc Natl Acad Sci USA, 2000, 97 (8) :4345-4350.
    [3]NAGATA K, TAKAHASHI M, KIRYU-SEO S, et al.Distinct functional consequences of ECEL1/DINE missense mutations in the pathogenesis of congenital contracture disorders[J].Acta Neuropathol Commun, 2017, 5 (1) :83.
    [4]LI YP, SONG LP, QIU SD, et al.The appliance of lentivirus vector in cancer theray[J].Mod Oncol, 2006, 14 (12) :1615-1617. (in Chinese) 李跃萍, 宋丽萍, 邱曙东, 等.慢病毒载体在肿瘤基因治疗中的应用[J].现代肿瘤医学, 2006, 14 (12) :1615-1617.
    [5]FRANKEL AD, YOUNG JA.HIV-1:Fifteen proteins and an RNA[J].Annu Rev Biochem, 1998, 67:1-25.
    [6]WYSOCZYNSKI M, RATAJCZAK MZ.Lung cancer secreted microvesicles:Underappreciated modulators of microenvironment in expanding tumors[J].Int J Cancer, 2009, 125 (7) :1595-1603.
    [7]ZHANG L, LIU QY, HU T, et al.The construction of high-efficiency packaging system of the 3rd lentivirus[J].Genom Appl Biol, 2009, 28 (2) :326-330. (in Chinese) 张磊, 刘庆友, 胡天, 等.第三代慢病毒高效率包装系统的建立[J].基因组学与应用生物学, 2009, 28 (2) :326-330.
    [8]BRECKPOT K, AERTS JL, THIELEMANS K.Lentiviral vectors for cancerimmunotherapy:Transforming infectious particles into therapeutics[J].Gene Ther, 2007, 14 (11) :847-862.
    [9]ESCORS D, BRECKPOT K.Lentiviral vectors in gene therapy:Their current status and future potential[J].Arch Immunol T-her Exp (Warsz) , 2010, 58 (2) :107-119.
    [10]KAFRI T, BLOMER U, PETERSON DA, et al.Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors[J].Nat Genet, 1997, 17 (3) :314-317.
    [11]MAO Y, YAN R, LI A, et al.Lentiviral vectors mediate long term and high efficiency transgene expression in hek 293Tcells[J].Int J Med Sci, 2015, 12 (5) :407-415.
    [12]KAHLERT C, KLUPP F, BRAND K, et al.Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases[J].Cancer Sci, 2011, 102 (10) :1799-1807.
    [13]LIN Y, DESAI A, GESRSON SL.Lentiviruses:Vectors for cancer gene therapy[M].In:Roth J, editor.Gene Based Therapies for Cancer, Current Cancer Research.Springer Science, 2010.
    [14]VUCIC D, FAIRBROTHER WJ.The inhibitor of apoptosis proteins as therapeutic targets in cancer[J].Clin Cancer Res, 2007, 13 (20) :5995-6000.
    [15]KOCK N, KASMIEH R, WEISSLEDER R, et al.Tumor theraphy media-ted by lentiviral expression of sh Bcl-2 and S-TRAIL[J].Neo-plasia, 2007, 9 (5) :435-442.
    [16]ZHAO B, YANG C, YANG S, et al.Construction of conditional lentivir-Us-mediated shRNA vector targeting the human Mirk gene and identification of RNAi efficiency in rhabdomyosarcoma RD cells[J].Int J Oncol, 2013, 43 (9) :1253-1259.
    [17]LING X, ARLINGHAUS RB.Knockdown of STAT3 expression by immunocompetent mice[J].Cancer Res, 2015, 65 (7) :2532-2536.
    [18]SUMIMOTO H, MIYAGISHI M, MIYOSHI H, et al.Inhibition of growth and invasive ability of melanoma RNA interference[J].Oncogene, 2014, 23 (36) :6031-6039.
    [19]PUTRAL LN, BYWATER MJ, GU W, et al.RNA interference against hunman papilloomavirus oncogenes in cervical cancer cells result in increased sensitivitity to cisplatin[J].Mol Pharmacol, 2015, 68 (5) :1311-1319.
    [20]YE XS, LIU T, GONG YP, et al.Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 singlefactor resistant cell line K562/MDR1[J].Leuk Res, 2009, 33 (8) :1114-1119.
    [21]XIE SM, FANG WY, LIU Z, et al.Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin[J].Transl Med, 2008, 6 (1) :55-63.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1336) PDF downloads(283) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return